Martin van den Bent
MD, PhD
Professor of Neuro-Oncology
👥Biography 个人简介
Martin van den Bent led EORTC 26951 and co-analyzed RTOG 9402 establishing that 1p/19q-codeleted oligodendroglioma patients achieve dramatic long-term survival benefit from adjuvant PCV chemotherapy after radiotherapy. His work transformed treatment of IDH-mutant 1p/19q-codeleted gliomas. He has been central to European neuro-oncology trials for decades.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Martin van den Bent 的研究动态
Follow Martin van den Bent's research updates
留下邮箱，当我们发布与 Martin van den Bent（Erasmus MC Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment